Coloplast

This week, our Coloplast North America Team welcomed President & CEO Kristian Villumsen and Executive Vice President & CFO Anders Lonning Skovgaard at our U.S. Headquarters in Minneapolis. Employees had the opportunity to sit with Kristian and Anders and gain their perspectives on innovation, growth, and technology within this market. These conversations reinforced the importance of our work across North America and highlight the impact our teams have towards driving our mission of making life easier for people with intimate healthcare needs. We’re expanding our team at our U.S Headquarters in Minneapolis, as well as field-based positions across the country. Take a look at the latest vacancies here: https://lnkd.in/gFy6di3 #Coloplast #MakingLifeEasier #CareersThatMakeADifference

Today, we marked International Women’s Day by hosting an internal panel discussion with global voices. Men and women from across Coloplast shared their views on personal and professional life, ideas on how to accelerate gender balance, their personal career journeys, and how to be a leader that fosters connection, trust, and sense of belonging. We are committed to creating a culture of inclusion where everyone thrives, so that we can perform our best. Together, this is how we make life easier for people with intimate healthcare needs. #Coloplast #MakingLifeEasier #CareersThatMakeADifference #InternationalWomensDay #IWD2025 #AccelerateAction

🔍 Verbeter de efficiëntie van uw consulten met de MS blaas-check! 🔍 De gevalideerde MS blaas-check is een waardevol hulpmiddel voor zorgprofessionals om de gezondheid van de blaas bij MS-patiënten te monitoren. Enkele tips voor optimaal gebruik: *Vooraf invullen: Stuur de check per e-mail naar de patiënt voor hun afspraak. *Actuele informatie: Laat patiënten de check invullen bij aanmelding. *Continue monitoring: Overweeg periodieke invullingen voor constante zorg. Bestel nu uw nieuwe scheurblok of digitale invul-pdf! 📄 https://lnkd.in/e6S8BrCi #ms #multiplescerosis #blaascheck #blaasgezondheid #ondersteundendmateriaal #kwaliteitvanleven #publicatie #inzicht #zelfbeoordelingstool 

Celebrating 25 years of SpeediCath®! 🎉 As the first instantly ready-to-use coated catheter, SpeediCath has made life easier for thousands of people around the world. That’s why we’re celebrating this milestone, as it is a reminder of our commitment to keep innovating and always strive for better. Thank you to all of those who have been part of the journey for 25 years with SpeediCath and helped us redefine continence care. #Coloplast #MakingLifeEasier #SpeediCath #innovation #CareersThatMakeADifference

This morning, we conducted the first of two global meetings being held today, livestreamed to thousands of colleagues all over the world. This quarter, the meetings included a glimpse into the ongoing work to build our next Coloplast Group Strategy that will set our strategic direction towards 2030, and our CEO Kristian Villumsen answered a range of questions submitted by our global colleagues in an ‘Ask Me Anything’ Q&A. We also had a closer look at our Q1 results with CFO Anders Lonning Skovgaard, which you can read more about here: https://lnkd.in/e-PnpWvF #Coloplast #MakingLifeEasier #CareersThatMakeADifference

🌟 Rencontres & Echanges autour de la prise en charge de la femme sous auto-sondage : un succès collectif ! 🌟 Durant 2 jours, nous avons réunis plus de 100 professionnels de santé venus de toute la France, lors d’un évènement autour des enjeux quotidiens de la prise en charge des femmes auto-sondées. 🧍♂️🧍♀️ Les infections urinaires, les complications, l’acceptabilité du sondage intermittent ont été au cœur des échanges mettant en évidence les nombreux défis liés à la prise en charge des troubles urinaires, plus particulièrement chez la femme. Comment pouvons-nous agir en tant qu'acteurs du parcours de soin pour améliorer cette prise en charge ? 🔍 Pour répondre à cette question, nous avons co-construit un programme avec un comité scientifique composé de 8 experts de renom. Les discussions ont mis en lumière des solutions concrètes et des approches novatrices et nous sommes ravis d'annoncer que 100% des participants estiment que cet évènement aura un impact significatif sur leur pratique. 🤩 Pour (re)découvrir l'innovation Coloplast et accéder à des contenus d'information actualisés, rendez-vous sur Coloplast Professional @https://lnkd.in/eBFd67RG Un grand merci à tous les membres du Comité scientifique pour leur collaboration précieuse dans la conception de cet évènement, aux intervenants et aux participants pour leur engagement ! Rendre la vie des patients plus facile … plus que des mots, une vraie mission ! 🤍 Xavier Biardeau, Pierre Denys Aurelien Dinh, @Dr Alexia Even, xavier Gamé, Frederique LE BRETON, Caroline THUILLIER, @Sophie Vercleyen, Sophie Cantero, Priscillia Legroux, Anne-sophie Para, marie charlotte Biard #Coloplast #Continence #Santé #Innovation #ProfessionnelsDeSanté #Partage #Impact

Coloplast expands Peristeen Light® portfolio with new product launch! Building on the launch of Peristeen Light 175mL last year, the new Peristeen Light 250mL features a larger water container and an optional extension tube, offering people living with constipation and faecal incontinence a choice in their daily bowel management routines. “We want to break down the barriers around transanal irrigation – a proven and effective treatment* that can help many more people than it does today. Peristeen Light is designed to be intuitive and easy to use. With this launch, we’re expanding our offering to meet the individual needs of people living with constipation and faecal incontinence,” says Marie Smidt, Vice President of Bowel Care at Coloplast. Read the full press release here: https://lnkd.in/gE5ZVzd6 #Coloplast #MakingLifeEasier #PeristeenLight #BowelCare #continence *Christensen P, Bazzocchi G, Coggrave M, et al., A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006; 131(3):738-47 https://lnkd.in/gH9i2wGu Peristeen Light is a CE-marked medical device. Availability is dependent on the individual country's regulatory process. Not available in the US.

Coloplast expands Peristeen Light® portfolio with new product launch! Building on the launch of Peristeen Light 175mL last year, the new Peristeen Light 250mL features a larger water container and an optional extension tube, offering people living with constipation and faecal incontinence a choice in their daily bowel management routines. “We want to break down the barriers around transanal irrigation – a proven and effective treatment* that can help many more people than it does today. Peristeen Light is designed to be intuitive and easy to use. With this launch, we’re expanding our offering to meet the individual needs of people living with constipation and faecal incontinence,” says Marie Smidt, Vice President of Bowel Care at Coloplast. Read the full press release here: https://lnkd.in/gE5ZVzd6 #Coloplast #MakingLifeEasier #PeristeenLight #BowelCare #continence *Christensen P, Bazzocchi G, Coggrave M, et al., A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006; 131(3):738-47 https://lnkd.in/gH9i2wGu Peristeen Light is a CE-marked medical device. Availability is dependent on the individual country's regulatory process. Not available in the US.

𝗭𝗼𝗼𝗺 𝘀𝘂𝗿 𝗖𝗼𝗹𝗼𝗽𝗹𝗮𝘀𝘁 𝗮𝘃𝗲𝗰 𝗕𝗙𝗠𝗧𝗩 ! 🔗 BFMTV met à l'honneur la mission des Laboratoires Coloplast : améliorer la qualité de vie des personnes souffrant de troubles intimes. Dans cette interview, nous explorons : - L’histoire de Coloplast - L’engagement de Coloplast en faveur de l’innovation - Les enjeux RSE Ne manquez pas cette opportunité d'en apprendre davantage sur une entreprise qui fait une réelle différence ! 🌍 #Innovation #Santé #MedTech #QualitéDeVie #Coloplast #BFMTV

“I look forward to an exciting 2025!” says our CEO Kristian Villumsen in connection to today’s announcement of our financial results.   We deliver 8% organic growth and an EBIT margin of 27% in the first quarter of 2024/25. These numbers reflect our commitment to helping more and more people with intimate healthcare needs live better lives.   Check out the video below to learn more 👇                       #Coloplast #MakingLifeEasier